Melissa Etheridge Announces Inaugural R.I.S.E. Summit Focused on Addiction Recovery

Grammy-winning rock icon Melissa Etheridge is set to host her first-ever R.I.S.E. Summit on November 12 at AV Irvine in California. The event, organized by the Etheridge Foundation, seeks to unite clinical experts, advocates, and those with personal experience to explore new frontiers in addiction recovery.
The centerpiece of the summit will be a compelling fireside chat between Etheridge and renowned addiction specialist Dr. Gabor Maté, author of the seminal work In the Realm of Hungry Ghosts: Close Encounters with Addiction.
Sharing the name of her latest studio album released earlier this year, the summit serves as a continuation of the singer’s advocacy for healing and resilience. The Etheridge Foundation was established as a deeply personal mission, following the tragic death of the singer’s son, Beckett Cypher, who passed away from an opioid overdose in 2020. “After losing my son, I knew I wanted to help other families find new pathways to healing,” Etheridge shared in a statement.
The event is designed for a diverse audience, ranging from researchers to families affected by addiction. Key programming will center on the latest developments in psychedelic-assisted therapies and other unconventional treatment modalities. R.I.S.E. (an acronym for Research, Innovation, Science, and Education) aims to be the most comprehensive in-person conference regarding the role of psychedelics in addiction medicine.
Discussion panels will cover a wide array of topics, including the study of ibogaine, psilocybin, MDMA, ketamine, and cannabis, alongside an important spotlight on indigenous-led efforts to protect traditional plant medicine and biocultural history.
For those interested in attending, tickets and additional information are available via the official Etheridge Foundation website. Following the public summit, the foundation will host a private, invitation-only working session on November 13 to help leading clinicians and researchers draft consensus models for treating opioid use disorder and related addictions.


